Literature DB >> 27767187

Management of fluoroscopy-induced radiation ulcer: One-stage radical excision and immediate reconstruction.

Kai-Che Wei1,2, Kuo-Chung Yang3,4, Lee-Wei Chen3,4, Wen-Chung Liu3,4, Wen-Chieh Chen5,6, Wen-Yen Chiou7, Ping-Chin Lai8.   

Abstract

With increasing use of cardiac fluoroscopic intervention, the incidence of fluoroscopy-induced radiation ulcer is increasing. Radiation ulcer is difficult to manage and currently there are no treatment guidelines. To identify the optimal treatment approaches for managing cardiac fluoroscopy-induced radiation ulcers, we retrospectively reviewed medical records of 13 patients with fluoroscopy-induced radiation ulcers receiving surgical interventions and following up in our hospital from 2012 to 2015. Conventional wound care and hyperbaric oxygen therapy were of little therapeutic benefit. Twelve patients received reconstruction with advancement flap or split thick skin graft. One-stage radical excision of radiation damaged area in eight cases with immediate reconstruction led to better outcomes than conservative excisions in four cases. Radical surgical excision to remove all the radiation damaged tissues in combination with immediate reconstruction appears to offer the optimal treatment results for cardiac fluoroscopy-induced radiation ulcers. Adequate excision of the damaged areas in both vertical (to the muscular fascia) and horizontal (beyond the sclerotic areas) dimension is pivotal to achieve good treatment outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27767187      PMCID: PMC5073289          DOI: 10.1038/srep35875

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Although guidelines for a safe radiation use during interventional procedures have been proposed123 and followed for years, cases with radiation injuries are still seen in the clinic. This may relate to the complexity or repetitive courses required to achieve acceptable cardiac outcomes. Recently, we noticed an increasing incidence of severe radiation dermatitis in our hospital4. Moreover, the trend is worldwide5678910111213. The managements for skin damages resulting from radiotherapy and those from cardiac catheterization are very different. This is because the radiation beams used in these two settings are different in term of physics characteristics, energy levels, biological reactions and depth-dose distribution. Radiotherapy for cancer uses either beta ions or high-level energy photons at the energy level of mega-electron volts (MeV) or mega-volts (MV), while the radiation source for fluoroscopy is X-rays with a low energy level between 40 and 140 kilo-volts (KV). When a high-level radiation photon beam enters the body, it loses only little energy in the skin and subcutaneous tissue and deposits most of its energy at the deeper area (Fig. 1), whereas the energy of X-ray is absorbed within a few centimeters from the skin surface (Fig. 1). So far, few studies focused on the managements of fluoroscopic induced radiation ulcer. This study was aimed to identify the optimal treatment approaches for managing cardiac fluoroscopy-induced radiation ulcers by examining the impact of these approaches on the healing of radiation ulcer.
Figure 1

Depth dose curves in water or soft tissues for various quantities of radiation beams.

Line red: linear accelerator 6 MV photon beam. Line green: linear accelerator 10 MV photon beam. Line purple: 100 kV X-rays filtered with HVL = 2 mm Al.

Material and Methods

This retrospective study complied with the guidelines of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Kaohsiung Veterans General Hospital, a tertiary referral center in southern Taiwan, with institutional Review Board approval (No. VGHKS15-CT3-08). By reviewing medical records from 2012 to 2015 in our hospital, thirteen cases with radiation ulcers were identified. All these 13 patients required surgical interventions to treat their cardiac fluoroscopic related ulcers. Their demographic data, procedures received, skin changes, surgical interventions, treatment outcomes and the associated complications were recorded and analyzed (Table 1 and Supplement Table 1).
Table 1

The summary of patients’ characteristics and demographic data.

Patient numberExcision Group
SexAgeCo-morbiditiesRadiation ExposureSurgical procedures & Outcome
Conservative excision (CE) versus Radical excision (RE)Numbers of ProceduresReconstructionOutcomeTime to Complete HealComplicationsFollow-up Time **
1CE M81HTN, Dyslipidemia, CKD (Cr 2.2)5NDNot healedNAUnstable angina22 months
2M82DM, HTN, CHF, CKD (Cr 3.1)3Local flap X 1 wound closure X 1Healed4 monthsWound dehiscence for many times15 months
3M45DM, HTN, Dyslipidemia3Rotation flap X 2 wound closure X 1Healed6 monthsPoor healing and flap necrosis in the wound edge16 months
4M62DM, HTN, Liver cirrhosis3Rotation flap X 2Not healedNAPoor healing and necrosis of flap15 months
5M52DM, HTN3Local flap X 2 wound closure X 2Healed5 monthsWound dehiscence for many times5 months
6RE+FlapM52DM, Dyslipidemia3Rotation flap X 1Healed2 weeksNil15 months
7M52DM, HTN, Dyslipidemia4Local flap X 1Healed3 weeksNil14 months
8M60DM, HTN, Dyslipidemia3Local flap X 1Healed2 weeksNil13 months
9M43DM, HTN, Dyslipidemia3Local flap X 1Healed2 weeksNil15 months
10M50HTN, Dyslipidemia, Hyperuricemia3Rotation flap X 1Healed3 weeksNil7 months
11RE+STSGM70HTN*3STSG X 1Healed4 weeksNil21 months
12M55HTN3STSG X 1Healed2 weeksNil29 months
13M57HTN, Dyslipidemia4STSG X 1Healed2 weeksNil8 months

NA: Not applicable; ND: Not done.

CHF: Congestive heart failure; CKD: Chronic kidney disease; DM: Diabetes mellitus; HTN: Hypertension.

STSG: Split thickness skin graft.

*This 70 year-old man received elctrophysiologic ablation for PSVT/aVRT, not percutaneous coronary intervention.

**Follow-up time is calculated since after the latest operation.

Results

All of the 13 cases were male, and their mean age was 58.5 ± 12.4 years (range: 43 to 81 years). Eight of them had diabetes mellitus; but none of these diabetic cases had history of diabetic ulcers in limbs. None of these 13 cases had autoimmune disease or peripheral arterial occlusive disease. Twelve patients received percutaneous coronary interventions for coronary artery disease, and one patient underwent electrophysiological ablation for a refractory supraventricular accessory pathway. Notably, fluoroscopic interventions were performed at least three times in all patients. The estimated accumulative peak skin dose is 19.1 ± 5.3 Grays (group A, range: 14.3 to 28.8) and 24.7 ± 7.1 Gy (Group B and C, range: 17.8 to 40.1) (Supplement Table 1). The radiation ulcers were found in right subscapular and inner arm areas in 12 cases, whereas one had his lesion at the left lower back. All patients showed typical manifestations of fluoroscopy-induced radiation ulcer, with a sharply-demarcated rectangle or square patch and central ulceration. The most common symptom of these patients was intolerable pain. At the first presentation to the surgical clinic, the severity of ulcers of each patient had been all graded as stage 4 based on CTCAE v4.03 Grade Severity Score. All cases had non-healing ulcers, which often worsened with conventional wound care, for at least 3 months. Five cases received hyperbaric oxygen therapy before surgery but no therapeutic effects were noted. One case received vacuum-assisted wound closure and hyperbaric oxygen therapy after repetitive conservative debridement. Although his wound became smaller, it failed to heal even after following up for 1 year. Like other cardiac diseases patients, repetitive anesthesia and wound debridement increase the risk of cardiac attack in these patients. One of our patients indeed developed unstable angina during debridement and need further cardiac fluoroscopic interventions to control his cardiac ischemia. We categorized our patients into three groups according to their treatment modalities (Table 1): Group A: conservative debridement with/without reconstruction flap at later stage; Group B: radical debridement plus immediate reconstruction with local advancement flap; Group C: radical debridement plus immediate reconstruction with split-thickness skin grafting (STSG).

Group A (Conservative debridement with/without reconstruction flap at later stage)

The first five cases (case 1 to case 5) underwent three to five sessions of conservative debridement (Fig. 2), aiming to remove only the necrotic ulcerated area with minimal tissue destruction of the surrounding sclerotic area. We found that these wounds inevitably continued to worsen after this approach. Reconstruction with localized rotation flaps were performed at the later stage in four cases, however, all these reconstruction flaps failed.
Figure 2

Group A: Conservative debridement with/without reconstruction flap at later stage.

(a) An 81-year-old man (case 1) had a painful sharply-demarcated square-shaped patch with a centrally located thick eschar (4.5 × 2.5 cm) and surrounding fibrosis for 5 months on his right sub-scapular area. This lesion appeared 2 months after per-cutaneous coronary intervention. (b) After three attempts of conservative debridement (only of the ulcerated area) and regular wound care within two months, the ulcer was clean but not healed. (c) After regular hyperbaric oxygen therapy and wound care with vacuum-assisted closure for 6 months, the ulcer became smaller but still did not heal.

Group B (Radical excision plus immediate local advancement flap)

Patients in this group (case 6 to case 10), the debridement (excision) margins were extended laterally to the outer zone (exceeding the white sclerotic area) of damaged skin and vertically deep to the muscular fascia layer (Figs 3 and 4). Reconstruction with a rotation flap (Fig. 3) or local advancement fasciocutaneous flap (Fig. 4) was performed at the same time. All cases had immediate pain relief and achieved good wound healing without major complications.
Figure 3

Group B: Radical excision and immediate reconstruction of rotation flap.

(a) A 52-year-old man (case 6) presented with a typical fluoroscopic radiation-induced skin lesion as a target-like plaque with three differently-colored rims and central ulceration. (b) Radical excision of necrotic and sclerotic areas with a deep margin to muscular fascia layer was performed. (c) Immediate reconstruction with local rotation fasciocutaneous flap was done. Wound healed smoothly one month after surgery. No recurrence was noted in the following 15 months.

Figure 4

Group B: Radical excision and immediate local advancement flap.

(a) A 52-year-old man (case 7) had a deep necrotic ulcer with erythematous-to-brownish patch in the periphery for 10 months on his right subscapular and arm region. The lesion occurred 2 months after percutaneous coronary intervention. (b) Radical excision of necrotic and sclerotic areas with a deep margin to muscular fascia layer was performed. (c) Local advancement flap was performed and wound healed two weeks later. No recurrence was noted in the following 14 months.

Group C (Radical excision plus immediate STSG)

Patients in this group (case 11 to 13) received radical excision (the same excision method as group B) and immediate coverage with split thickness skin graft (Fig. 5). All three patients achieved good wound healing within 4 weeks without obvious complications.
Figure 5

Group C: Radical excision and immediate split thick skin graft (STSG).

(a) A 70-year-old man (case 11) presented with a large deep necrotic ulcer with bacterial infection and pus formation, surrounded by a square-shaped erythematous sclerotic plaque for 6 months on his right lateral back. The lesion was found 1 month after electrophysiological ablation of cardiac accessory pathway. (b) Excision of all the sclerotic areas deep to the muscular fascia layer was done with immediate coverage with STSG. (c) Following up at 16th month in the clinic, good uptake of STSG was noted without recurrence.

Discussion

The aims of treating radiation ulcers include preventing infection, controlling pain, closing wounds and preventing malignancy. When planning an operation, clinicians should bear in mind that the zone of radiation injury is larger than the area exhibiting clinical symptoms and signs, and inadequate excision inevitably leads to treatment failure. In addition, the residual radiation damaged tissue may increase the risk of subsequent radiation-related malignancies. As a general rule, the severity of radiation injury increases with accumulated exposure dose i.e. if the exposed dose is less than a threshold, the radiation dermatitis is typically not clinically detectable but once the accumulated exposure dose exceeds the threshold, radiation dermatitis occurs. To recover from the injury, the damaged tissues need stem cells either from radiated area or adjacent tissues. If enough number of stem cells still present, the lesion will usually respond to the conventional wound care. On the other hand, when a radiation ulcer appears, the adjacent tissues tend to suffer severe radiation damage as well. As a result, these tissues not only have limit ability to facilitate lesion site’s recovery but also impose further stresses on healing processes. Therefore, complete removal of these severely damaged tissues is the cornerstone of radiation ulcers managements. From our experience, this principle applies to all the radiation ulcers treatments, irrespective of the accumulated exposure dose. Another possible cause of radiation ulcer is radiation vasculopathy14, which leads to vessel occlusion and tissue ischemia in the irradiated region. This will also jeopardize the wound healing processes and result in poor adhesion of the reconstruction flap. Radiation vasculopathy is also the underlying reason why these patients frequently experience severe intolerable pain, which is of similar characteristics as ischemic pain, and why reconstruction flaps frequently fail to heal the radiation ulcer. Cardiac fluoroscopic procedures adopt the radiation energy levels at about 100 kV. Thus, most of the fluoroscopy-induced radiation damages are located within the superficial layers of skin and their severity decrease steadily down to deeper area (Supplement Fig. 1). A typical lesion of a fluoroscopy-induced radiation ulcer is a rectangle or square lesion with three concentric zones in different colors. The shape of the lesion matches the fluoroscopic exposure field, and the color distribution correlates with the radiation dose that was applied (Fig. 3a). Necrotic tissue, the center of the lesion, has the highest radiation dose, whereas the outermost pigmented dry-surface “flame burn-like” zone has the lowest radiation dose. The middle layer, the white sclerotic telangiectasia zone, has a medium dose of radiation. The sclerosis indicates loss of adnexal structures where follicular stem cells resides in. Thus, radiation wound in the sclerotic zone is difficult to heal. Based on these, the horizontal excision margin should aim to remove the sclerotic zone as we did in group B and C patients. However, to decide the vertical excision depth is more challenging. Theoretically, the most severely damaged zone is within the uppermost 2 cm below the skin surface (Supplement Fig. 1). Hence, the depth of excision should be at least 2 cm. On top of this, excision as deep as presence of viable healthy-looking tissue is also critical. Nonetheless, in our experience, none of the excision depths exceeded muscular layer. To achieve primary wound healing, reconstructive methods are usually necessary. However, it is not known whether a vascularized flap is better than a simple skin grafting in bringing wound healing in these patients1516. Our study showed that there are no differences in the outcomes of group B patients (radical excision plus vascularized fasciocutaneous flap) and group C patients (radical excision plus STSG). Our results support the concept that an adequate excision, independent of the methods of reconstruction, is the critical point for treating radiation ulcers.

Conclusion

In the management of fluoroscopy-induced chronic radiation ulcers, one-stage radical excision with immediate wound reconstruction showed the best result in our study. It alleviates patients’ suffering and the risk of repetitive anesthesia. Adequate excision of the radiation damaged areas including the vertical (to the viable healthier muscular fascia) and the horizontal (beyond the sclerotic and telangiectasia area) dimensions is the key to achieve good treatment outcomes.

Limitation

This study focuses on the most severe radiation injuries (radiation ulcers), thus our findings can not be applied to the management of radiation dermatitis. Although the underlying diseases of these patients were diverse, none of them had history of diabetic ulcer, or peripheral arterial occlusive disease or autoimmune disease.

Additional Information

How to cite this article: Wei, K.-C. et al. Management of fluoroscopy-induced radiation ulcer: One-stage radical excision and immediate reconstruction. Sci. Rep. 6, 35875; doi: 10.1038/srep35875 (2016).
  16 in total

Review 1.  Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient.

Authors:  T R Koenig; F A Mettler; L K Wagner
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

2.  Chronic radiodermatitis following percutaneous coronary interventions: a report of two cases.

Authors:  A Aerts; T Decraene; J J van den Oord; J Dens; S Janssens; P Guelinckx; M Flour; H Degreef; M Garmyn
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-05       Impact factor: 6.166

Review 3.  Radiation dose and radiation protection for patients and physicians during interventional procedure.

Authors:  Koichi Chida; Mamoru Kato; Yutaka Kagaya; Masayuki Zuguchi; Haruo Saito; Tadashi Ishibashi; Shoki Takahashi; Shogo Yamada; Yoshihiro Takai
Journal:  J Radiat Res       Date:  2010       Impact factor: 2.724

4.  Treatment of a radiation ulcer combining negative pressure wound therapy with flap reconstruction.

Authors:  Takeshi Nagata; Masao Fujiwara; Hidekazu Fukamizu
Journal:  J Dermatol       Date:  2013-07-09       Impact factor: 4.005

5.  Fluoroscopy-induced chronic radiation dermatitis.

Authors:  Alison Spiker; Zachary Zinn; William H Carter; Roxann Powers; Rodney Kovach
Journal:  Am J Cardiol       Date:  2012-09-14       Impact factor: 2.778

Review 6.  Ionizing radiation: the good, the bad, and the ugly.

Authors:  Julie L Ryan
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

7.  Real-time measurement of radiation exposure to patients during diagnostic coronary angiography and percutaneous interventional procedures.

Authors:  J T Cusma; M R Bell; M A Wondrow; J P Taubel; D R Holmes
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

8.  Total entrance skin dose: an effective indicator of maximum radiation dose to the skin during percutaneous coronary intervention.

Authors:  Koichi Chida; Yutaka Kagaya; Haruo Saito; Yoshihiro Takai; Shoki Takahashi; Shogo Yamada; Masahiro Kohzuki; Masayuki Zuguchi
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

9.  Supplementation of bone marrow aspirate-derived platelet-rich plasma for treating radiation-induced ulcer after cardiac fluoroscopic procedures: A preliminary report.

Authors:  Soh Nishimoto; Kenji Fukuda; Kenichiro Kawai; Toshihiro Fujiwara; Tomoko Tsumano; Kazutoshi Fujita; Masao Kakibuchi
Journal:  Indian J Plast Surg       Date:  2012-01

10.  STROBE--Radiation Ulcer: An Overlooked Complication of Fluoroscopic Intervention: A Cross-Sectional Study.

Authors:  Kai-Che Wei; Kuo-Chung Yang; Guang-Yuan Mar; Lee-Wei Chen; Chieh-Shan Wu; Chi-Cheng Lai; Wen-Hua Wang; Ping-Chin Lai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more
  2 in total

1.  Management of radiation-induced ulcers by singlestage reconstructive surgery: a prospective study.

Authors:  T T Hoang; V Q Vu; D T Trinh
Journal:  Ann Burns Fire Disasters       Date:  2019-12-31

2.  An innovative targeted therapy for fluoroscopy-induced chronic radiation dermatitis.

Authors:  Kai-Che Wei; Shih-Fan Lai; Wei-Lun Huang; Kuo-Chung Yang; Ping-Chin Lai; Wan-Ju Wei; Tsung-Hsien Chang; Yun-Chen Huang; Ya-Chuan Tsai; Shin-Chih Lin; Sun-Jang Lin; Shih-Chieh Lin
Journal:  J Mol Med (Berl)       Date:  2021-10-23       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.